TOVX icon

Theriva Biologics

16 hedge funds and large institutions have $128K invested in Theriva Biologics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
16
Holders Change
+6
Holders Change %
+60%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$52.1K 120,031
Citadel Advisors
2
Citadel Advisors
Florida
$15.6K 36,018 +36,018 New
BFM
3
Boothbay Fund Management
New York
$15.4K 35,601
VF
4
Virtu Financial
New York
$15K 34,495 +34,495 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$8.07K 18,601 -82 -0.4%
TSS
6
Two Sigma Securities
New York
$7.73K 17,818 +17,818 New
XT
7
XTX Topco
Cayman Islands
$7.46K 17,187 +17,187 New
BlackRock
8
BlackRock
New York
$3.28K 7,568
Osaic Holdings
9
Osaic Holdings
Arizona
$1.49K 857 -27 -3%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$1.3K 3,000 +3,000 New
CS
11
Clear Street
New York
$43 100 +100 New
Bank of America
12
Bank of America
North Carolina
$32 74 +33 +80%
SS
13
SBI Securities
Japan
$26 60 +50 +500%
IA
14
IFP Advisors
Florida
$5 11
PW
15
Pandora Wealth
Illinois
$2 4
UBS Group
16
UBS Group
Switzerland
$0 1 -7,850 -100%